Clinical study to evaluate the safety of investigational medicinal product called AD-O51.4 in patients with advanced malignancies

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515687-31-01

Acronym

ADO-01-24

Enrollment

Registered

2025-01-27

Start date

2025-07-09

Completion date

Unknown

Last updated

2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients suffering from cancer without further treatment options.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026